TD Cowen Downgrades Blueprint Medicines (NASDAQ:BPMC) to Hold
TD Cowen cut shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Tuesday morning,Zacks.com reports. Several other brokerages have also issued reports on BPMC. Needham & Company LLC lowered shares of Blueprint Medicines from a “moderate buy” rating to a […]
TD Cowen cut shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Tuesday morning,Zacks.com reports. Several other brokerages have also issued reports on BPMC. Needham & Company LLC lowered shares of Blueprint Medicines from a “moderate buy” rating to a […]
